Mandatum Life Insurance Company’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Mandatum Life Insurance Company’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-4,824	Closed	-$227K	–	190
2016 Q4	$227K	Sell	4,824 -969	-17%	-$46K	0.03%	181
2016 Q3	$289K	Hold	5,793	–	–	0.04%	175
2016 Q2	$279K	Sell	5,793 -1,290	-18%	-$61.4K	0.04%	176
2016 Q1	$324K	Sell	7,083 -5,733	-45%	-$268K	0.04%	164
2015 Q4	$690K	Buy	+12,816	New	+$674K	0.09%	108

Other funds holding IHE

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PAG

Pinnacle Advisory Group Columbia, Maryland $2.17B AUM 39.21% 1-Year Est. Return

AWA

ARS Wealth Advisors St. Petersburg, Florida $556M AUM 30.03% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Spinnaker Trust Portland, Maine $1.81B AUM 17.83% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

RTS

Round Table Services Westfield, New Jersey $508M AUM 16.36% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Mandatum Life Insurance Company's IHE Position: Q1 2017 in Review

Mandatum Life Insurance Company sold out of iShares US Pharmaceuticals ETF (IHE) in Q1 2017, closing a stake of 4,824 shares — an estimated $227K sold.

Mandatum Life Insurance Company first reported a position in IHE in Q4 2015 and held it in 5 quarters. The position peaked at $690K in Q4 2015. 97 funds tracked by Wall St. Rank hold IHE as of Q1 2017.

Mandatum Life Insurance Company reported no remaining iShares US Pharmaceuticals ETF position as of Q1 2017 after selling out during the quarter.
Mandatum Life Insurance Company sold 4,824 iShares US Pharmaceuticals ETF shares in Q1 2017, an estimated $227K.
Mandatum Life Insurance Company first reported a position in iShares US Pharmaceuticals ETF in Q4 2015 and held it in 5 quarters.
Mandatum Life Insurance Company's iShares US Pharmaceuticals ETF position peaked at $690K in Q4 2015.
97 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2017.

Based on Mandatum Life Insurance Company's 13F filing for Q1 2017, filed 9 May 2017.